Denali Capital Acquisition Corp. DECA
11.43 USD 0.00 (+0.00%)
At closeMar 9, 2026, 4:00 PM EDT
11.43 Day range 11.43
4.05 52-week range 14.10
- YTD
- 0.00%
- 1 year
- 0.00%
News
businesswire.com Florida DECA Partners with Kaplan to Expand College and Career Readiness for Students Statewide FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #education--Florida DECA, which prepares emerging leaders for careers in marketing, finance, hospitality, and management, has partnered with Kaplan.
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the “Trust…
globenewswire.com Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that on April 11, 2025, the Company's shareholders voted in favor…
globenewswire.com Denali Capital Acquisition Corp. Announces Adjournment of Extraordinary General Meeting of Shareholders to April 11, 2025 at 10:00 AM ET. NEW YORK, NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that the Company's Extraordinary General Meeting of Shareholders…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the…
reuters.com Semnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 bln deal Semnur Pharmaceuticals, a wholly owned subsidiary of Scilex Holding Company , will go public via a merger with special purpose acquisition company Denali Capital Acquisition Corp in a $2.5 billion…
globenewswire.com Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion PALO ALTO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company's trust account (the…
globenewswire.com Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that the Company's shareholders voted in favor of approving…
reuters.com Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital Drug developer Semnur Pharmaceuticals said on Tuesday it has signed a letter of intent to go public through a merger with special purpose acquisition company Denali Capital Acquisition Corp in a…
globenewswire.com Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination PALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative…
globenewswire.com Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that Denali and Longevity Biomedical, Inc. have mutually agreed…
globenewswire.com Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that Denali and Longevity Biomedical, Inc. have mutually agreed…
globenewswire.com Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination NEW YORK, NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that an aggregate of $50,000 has been deposited into the…
benzinga.com Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 126 companies set new 52-week lows.